The nation of Zimbabwe has declined a significant American healthcare agreement valued at $367m (£272m) spanning five years over the United States' request for confidential information.
This rejection became public after a government memo dated December was leaked, revealing that Head of State Emmerson Mnangagwa felt the arrangement was "unbalanced".
A government representative has since clarified that the United States was seeking genetic material for research and commercial gain but refused to share the benefits from future medical innovations.
"We are forced to start the challenging and unfortunate task of winding down our support in Zimbabwe," stated American envoy to Zimbabwe Pamela Tremont in a statement.
Her embassy noted the US had donated more than $1.9bn for health programmes to Zimbabwe over the last twenty years.
A physicians' group in Zimbabwe has called for more talks to secure a deal suitable to all parties so the nation's vital HIV treatment initiative can continue.
Wider Background
This development comes after a comparable case in neighbouring Kenya, where a court blocked a similar deal with the US following concerns were filed about the safety of citizens' health data.
After resuming the presidency recently, US President Donald Trump has drastically cut overseas assistance and closed the key foreign aid agency.
USAID had managed aid for the US government, but Trump argued its expenditure was "inefficient" and his administration was seeking government-to-government agreements to enhance openness and accountability.
As per statements, 16 nations in Africa have so far agreed to these new health pacts, representing more than $18.3bn in committed funds.
Specifics of the Rejected Agreement
The money for Zimbabwe was intended to funded "tackling HIV/Aids, tuberculosis, malaria, maternal and child health, and preparing for epidemics".
"We believe this collaboration might have yielded extraordinary benefits for the people of Zimbabwe, especially the 1.2 million presently on antiretroviral therapy via American-funded initiatives," Tremont commented.
However, official spokesman Nick Mangwana maintained the proposed deal was "unequal".
"Our nation was requested to surrender its genetic material and health information over an extended period, without any equivalent assurance of access to any scientific breakthroughs – like new medicines or tests – that might result from that shared data," he stated.
"In essence, our country would provide the basic resources for scientific discovery with no certainty that the resulting innovations would be available to our citizens if a new health crisis emerge."
National Interest and Global Health
Mangwana further pointed out that the US's withdrawal from the global health body and its pursuit of one-on-one health agreements were undermining systems previously established through the global health agency.
Mangwana gave as an example its Pandemic Benefit-Sharing system designed to manage future pandemics.
"This framework is intended to guarantee that when a nation contributes its information, the benefits – including medicines and cures – are distributed fairly, not commercialised exclusively by those with the funds to create them."
Zimbabwe's reservations over the US deal "must not be interpreted as hostility towards the US," Mangwana stressed.
"We are open to further discussions with our US partners on how subsequent collaboration might be arranged in a manner that honours the sovereignty and dignity of each country."
Medical Community Reaction
The Zimbabwe College of Public Health Physicians (ZCPHP) stated it acknowledged the official position, but urged that talks need to persist given that a large portion of the country's Aids initiatives relied on international support.
"Where specific concerns arise, such as those relating to data governance or agreement terms, these can frequently be resolved via detailed discussion and negotiated safeguards," the group commented.
This impasse highlights the continuing challenges between accepting much-needed foreign assistance and safeguarding national sovereignty in an ever more interconnected world.